• Wednesday 29th of March 2023
  • Contact Us
Logo
  • Home
  • Government
  • Islamic Finance
  • Travel & Tourism
  • Banking
  • Oil & Gas
  • Cars
  • Real Estate
  • Aviation
  • Fashion
  • Technology
  • Telecom
Logo
  • Home
  • Government
  • Islamic Finance
  • Travel & Tourism
  • Banking
  • Oil & Gas
  • Cars
  • Real Estate
  • Aviation
  • Fashion
  • Technology
  • Telecom
    • Home
    • Government
    • Islamic Finance
    • Travel & Tourism
    • Banking
    • Oil & Gas
    • Cars
    • Real Estate
    • Aviation
    • Fashion
    • Technology
    • Telecom
Breaking News
  • CREDIT SUISSE AT1s: Pallas Partners forming Investor Group
  • Japanese Cuisine and Food Culture Human Resource Development Program: A training course was held inviting non-Japanese chefs
  • Hevolution Foundation Announces Formation of Scientific Advisory Panel of Renowned Experts in Healthspan Science and Geroscience
  • NTT Commences Sales of the Network OS Beluganos
  • United in Purpose: CSG Launches Inaugural Impact Report
  • Two Foreign Chefs Attained Gold Certification at Yanagihara Cooking School of Traditional Japanese Cuisine under the “Certification of Cooking Skills for Japanese Cuisine in Foreign Countries” Program
  • Nothing Launches Ear (2) – The Ultimate Hi-Res Audio Certified True Wireless Earbuds
  • ASM Global Unveils Ambitious Plan Transforming Its Global Venue Portfolio Into World’s Most Sustainable Collection
  • Africell Angola Races Towards 10 Million Subscribers Using Csmart Digital BSS Platform
  • Iran’s steel output up 21% y/y in Jan-Feb: Worldsteel

healthcare

March 16, 2023

University of Nebraska Medical Center and ANANDA Scientific announce First Patient Enrolled in FDA-approved clinical trial for Post-Traumatic Stress Disorder (PTSD)

The University of Nebraska Medical Center (UNMC) and ANANDA Scientific Inc. today announced that the first patient has been enrolled in an FDA-approved clinical trial evaluating Nantheia™ ATL5, an investigational......

March 16, 2023

Innovation in Resistance Management: VECTRONTM T500, a New Vector Control Product, is Prequalified by the World Health Organization (WHO)

VECTRONTM T500 is a new IRS product containing TENEBENALTM, the world’s first meta-diamide active ingredient (IRAC Group 30) developed by Mitsui Chemicals Agro which has a different......

March 13, 2023

Region’s first Global Robotic MedTech Forum to reveal latest advancements in robotic surgery

The US Society of Robotic Surgery and Crescent Healthcare (a Division of the Crescent Group of Companies) host the first Global Robotic MedTech Forum in the Middle East on 16 March......

March 9, 2023

Largest hospital in Middle East opens in Tehran

Iran has launched a mega hospital dubbed by authorities the largest in the Middle East region as President Ebrahim Raeisi vows his administration will be committed to complete unfinished......

March 8, 2023

Iran self-sufficient in making active ingredient of acetaminophen

Iran has announced self-sufficiency in making the active ingredient needed to manufacture acetaminophen drugs amid efforts in the country cut back reliance on foreigners for medical......

March 8, 2023

Iran, Singapore need to expand health cooperation

TEHRAN, Mar. 07 (MNA) – The director general of the international cooperation department of Iran's health ministry stressed the importance of expanding relations with Asian......

March 7, 2023

New Study Evaluates the Use of Masimo PVi® As an Indicator of Fluid Responsiveness to Guide Goal-Directed Fluid Therapy in Adult Neurosurgical Patients

Masimo (NASDAQ: MASI) today announced the findings of a prospective study published in the British Journal of Neurosurgery in which Dr. Ankita Dey and colleagues at institutions in Bathinda and Pondicherry, India evaluated......

February 23, 2023

Hikma delivers a resilient underlying performance in 2022

Hikma Pharmaceuticals PLC (‘Hikma’ or ‘Group’), the multinational pharmaceutical company, today reports its preliminary audited results for the year ended 31......

February 23, 2023

Ferrer Acquires Worldwide Rights to ASN90, an O-GlcNAcase Inhibitor From Asceneuron, Exclusively to Treat Progressive Supranuclear Palsy (PSP)

Spanish pharmaceutical company Ferrer and Swiss clinical stage biotechnology company Asceneuron announce the signing of a licensing agreement in which Ferrer obtains the exclusive worldwide......

February 23, 2023

LevitasBio Launches LeviSelect Suite of Cell Depletion & Enrichment Kits

LevitasBio, Inc. (www.levitasbio.com), a premier end-to-end sample processing and cellular analysis provider to the life sciences market, unveils a suite of LeviSelect™ cell depletion......

Top News

February 14, 2023
National Housing Movement project implementation speed high in Tehran province
February 10, 2023
Broadband mobile internet penetration rate in Iran at 121%: Regulator
February 9, 2023
Greenhouses being established in 180 hectares of land in Ardebil province


© 2020 TEHRAN Telegram.